ClinicalTrials.Veeva

Menu

Spinal Anaesthesia vs. General Anaesthesia for THA, TKA and UKA (RCT SAGA)

A

Anders Troelsen

Status and phase

Completed
Phase 4

Conditions

Osteoarthritis, Hip
Osteoarthritis, Knee

Treatments

Drug: General anaesthesia
Drug: Spinal anesthesia

Study type

Interventional

Funder types

Other

Identifiers

NCT05706844
2022-501221-21-00

Details and patient eligibility

About

The goal of this randomized clinical trial is to investigate the postoperative recovery following hip and knee arthroplasty procedures depending on the use of either spinal anaesthesia (SA) or general anaesthesia (GA).

The main questions are:

  • Are more patients able to be safely mobilized within 6 hours postoperatively when using GA compared to SA?
  • Does postoperative pain, nausea and vomiting, dizzyness, occurence of delirium and urinary retention differ between the anaesthetic methods?

Participants, scheduled for total hip, total knee and unicomartmental knee arthroplasty, will be randomized to recieve spinal anaesthesia or general anaesthesia in relation to surgery. At 6 hours postoperatively a physiotherapist will conduct a 5-meter walking test to evaluate whether the participant can be safely mobilized.

Enrollment

222 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical and radiological hip or knee osteoarthritis meeting the indications for primary total hip, total knee, or unicompartmental knee arthroplasty.
  • ≥18 years of age.
  • Able to speak and understand Danish
  • Able to give informed consent and must be cognitively intact.

Exclusion criteria

  • Lives in an institution.
  • Uses walking aid such as a walker or a wheelchair.
  • Terminal illness.
  • Has contraindications for either general or spinal anaesthesia.
  • Has objections to receiving either general or spinal anaesthesia.
  • Requires anxiolytics as premedication prior to anaesthesia.
  • Traumatic aetiology as a basis for surgical indication.
  • Altered pain perception and / or neurologic affection due to diabetes or other disorders.
  • Daily preoperative use of opioids > 30 mg of morphine milligram equivalents (MME).
  • Standard primary arthroplasty procedure is evaluated not to be suitable.
  • Women considered fertile but without sufficient birth control.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

222 participants in 2 patient groups

Spinal Anaesthesia (SA)
Experimental group
Description:
Patients undergoing total hip, total knee or unicompartmental knee arthroplasty are anaesthetized using: Plain or heavy Bupivacaine hydrochloride 10 mg (2 mL)
Treatment:
Drug: Spinal anesthesia
General Anaesthesia (GA)
Experimental group
Description:
Patients undergoing total hip, total knee or unicompartmental knee arthroplasty are anaesthetized using: Propofol (induction: 1.0-2.0 mg/kg. infusion: 3-5 mg/kg/hour) + Remifentanil (induction: 3-5 mcg/kg, infusion: 0.5 mcg/kg/min)
Treatment:
Drug: General anaesthesia

Trial documents
1

Trial contacts and locations

2

Loading...

Central trial contact

Anders Troelsen, MD, DMSc; Christian Bredgaard Jensen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems